Stay updated on Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a general 'Gastric cancer' term and a link to the Genetic and Rare Diseases Information Center, and updated the page revision to v3.4.2; these are minor metadata and labeling updates that do not change core study content or user interaction. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page now displays Revision: v3.4.1 (replacing v3.4.0); no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedUI and metadata updates include a glossary toggle, a new 'Last Update Submitted that Met QC Criteria' timestamp in Study Record Dates, and the 'Revision: v3.4.0' label, with 'No FEAR Act' shown as 'No FEAR Act data'.SummaryDifference0.1%

- Check39 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded state-level Locations (California, Kansas, Massachusetts, New York, Texas, Washington) and removed the corresponding state locations; Revision: v3.3.3.SummaryDifference0.5%

- Check89 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page.